Skip to main content

FINISHER Trial

As of January 2025, the FINISHER (Fight INflammation to Improve Outcome after aneurysmal Subarachnoid HEmorRhage) trial is ongoing, and its final results have not yet been published.
Place: Berlin, Germany

The study is designed to assess whether dexamethasone, an anti-inflammatory glucocorticoid, can improve outcomes in patients who have suffered an aneurysmal subarachnoid hemorrhage (aSAH). T

he trial is a multicenter, prospective, randomized, double-blinded, placebo-controlled phase III study. It plans to enroll 334 patients, who will be randomized to receive either dexamethasone or a placebo within 48 hours after the hemorrhage. 

The dexamethasone regimen consists of 8 mg three times daily for the first seven days, followed by 8 mg once daily from days eight to twenty-one. 

The primary outcome measure is the modified Rankin Scale (mRS) at six months, dichotomized to favorable (mRS 0-3) versus unfavorable (mRS 4-6) outcomes.

Source: Pub Med and Clinical Trials.gov.in 

Given your role as an Emergency Medicine Resident, the findings of the FINISHER trial, once available, 

For the most current information, I recommend monitoring updates from clinical trial registries and recent publications in reputable medical journals. The trial is registered on ClinicalTrials.gov under the identifier NCT05132920, where updates on its progress and results will be posted upon completion.


Another Similar Trial: 


Comments

Post a Comment

Popular posts from this blog

CRASH-3 TRIAL (Tranexamic Acid in Head Injury)

 
Post a Comment
Read more

Lignocaine Associated Systemic Toxicity (LAST)

  Lidocaine Associated Systemic Toxicity (LAST) Lidocaine Associated Systemic Toxicity (LAST) is a potentially life-threatening condition that occurs due to the excessive absorption of local anesthetics, particularly lidocaine, into the systemic circulation. LAST can result from inadvertent intravascular injection, overdose, or rapid absorption from highly vascularized areas.   Pathophysiology: Lidocaine, like other local anesthetics, works by blocking sodium channels, inhibiting the initiation and propagation of nerve impulses. However, when systemic levels of lidocaine become excessively high, these sodium channels are blocked in vital organs such as the heart and brain, leading to serious complications. Clinical Presentation: LAST can manifest with a variety of symptoms that often progress through two stages: Neurological Symptoms : Early signs include circumoral numbness, metallic taste, tinnitus, and dizziness. As toxicity increases, more severe symptoms such as seizures,...
Post a Comment
Read more

BLUNT TRAUMA TO EYE VARIOUS FINDINGS

Blunt trauma to the eye can result in a wide range of findings and injuries, depending on the force and direction of the impact. The Trauma can be due to Direct Injury Contre-coup Injury Shearing forces and shock waves. The eye is a delicate organ with several components, and trauma can result into open or closed globe injuries. Following are some of the findings and injuries commonly associated with blunt trauma to different components of the eye:         Eyelids and Surrounding Tissues: ü   Contusions and bruising of the eyelids and periorbital area. May give an appearance of Raccoon Eyes. ü   Lacerations or cuts on the eyelids. ü   Swelling and edema of the eyelids.         Conjunctiva: ü   Subconjunctival hemorrhage, which appears as redness on the white part of the eye. ü   Chemosis, which is swelling of the conjunctiva.         Cornea: ü ...
Post a Comment
Read more